Recent findings highlight that IL-6-driven STAT3 activation is especially pronounced in CD4+ T cells during the early phases of RA, and this is particularly evident in patients who test negative for anticitrullinated peptide antibodies (ACPA)-negative [44]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.